Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.

MLA

García-de-la-Mària, C., et al. “Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus Epidermidis.” Antimicrobial Agents and Chemotherapy, vol. 54, no. 7, July 2010, pp. 2781–86. EBSCOhost, https://doi.org/10.1128/AAC.01011-09.

APA

García-de-la-Mària, C., Marco, F., Armero, Y., Soy, D., Moreno, A., del Río, A., Almela, M., Cervera, C., Ninot, S., Falces, C., Mestres, C. A., Gatell, J. M., Jiménez de Anta, M. T., & Miró, J. M. (2010). Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy, 54(7), 2781–2786. https://doi.org/10.1128/AAC.01011-09

Chicago

García-de-la-Mària, C, F Marco, Y Armero, D Soy, A Moreno, A del Río, M Almela, et al. 2010. “Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus Epidermidis.” Antimicrobial Agents and Chemotherapy 54 (7): 2781–86. doi:10.1128/AAC.01011-09.